Ascend Wellness Seeks DEA Registration for Medical Cannabis Operations
Event summary
- Ascend Wellness Holdings filed DEA registration applications for its state-licensed medical cannabis operations on June 30, 2026.
- The applications cover dispensary operations across seven states where AWH operates.
- AWH's footprint includes 51 retail locations and over 260,000 square feet of cultivation, processing, and manufacturing facilities.
- CEO Sam Brill highlighted the move as a step toward broader industry normalization.
The big picture
Ascend Wellness's DEA registration applications come as the U.S. cannabis industry navigates evolving federal regulations. The rescheduling of medical marijuana to Schedule III marks a significant shift, potentially opening up new economic opportunities and aligning the sector with traditional business frameworks. AWH's move underscores the strategic importance of regulatory compliance in an increasingly complex market landscape.
What we're watching
- Regulatory Progress
- How the DEA's expedited registration pathway will impact medical cannabis operators.
- Industry Normalization
- Whether broader rescheduling reforms will create a level playing field for cannabis businesses.
- Market Expansion
- The pace at which AWH can scale its operations following regulatory approvals.